The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Genomic Biomarkers-Global Market Insights and Sales Trends 2025

Genomic Biomarkers-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1823161

No of Pages : 100

Ask Your Query

 

Synopsis

The global Genomic Biomarkers market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Biomarkers in various end use industries.

The expanding demands from the Diagnostic and Research Laboratories, Hospitals and Others,, are propelling Genomic Biomarkers market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiovascular Diseases segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Genomic Biomarkers market, driven by demand from China, the second largest economy with some signs of stabilising, the Genomic Biomarkers market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Biomarkers, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Genomic Biomarkers market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Genomic Biomarkers market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Biomarkers sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Genomic Biomarkers covered in this report include Thermo Fisher Scientific, Roche, Aepodia, Myriad Genetics, Eurofins Scientific, QIAGEN, Bio-Rad Laboratories, Genomic Health and Liquid Genomics, etc.

The global Genomic Biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Thermo Fisher Scientific
  • Roche
  • Aepodia
  • Myriad Genetics
  • Eurofins Scientific
  • QIAGEN
  • Bio-Rad Laboratories
  • Genomic Health
  • Liquid Genomics
  • Epigenomics
  • AROS Applied Biotechnology

Global Genomic Biomarkers market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Genomic Biomarkers market, Segment by Type:

  • Oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Others

Global Genomic Biomarkers market, by Application

  • Diagnostic and Research Laboratories
  • Hospitals
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Biomarkers companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Genomic Biomarkers
1.1 Genomic Biomarkers Market Overview
1.1.1 Genomic Biomarkers Product Scope
1.1.2 Genomic Biomarkers Market Status and Outlook
1.2 Global Genomic Biomarkers Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic Biomarkers Market Size by Region (2018-2029)
1.4 Global Genomic Biomarkers Historic Market Size by Region (2018-2023)
1.5 Global Genomic Biomarkers Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic Biomarkers Market Size (2018-2029)
1.6.1 North America Genomic Biomarkers Market Size (2018-2029)
1.6.2 Europe Genomic Biomarkers Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic Biomarkers Market Size (2018-2029)
1.6.4 Latin America Genomic Biomarkers Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic Biomarkers Market Size (2018-2029)
2 Genomic Biomarkers Market by Type
2.1 Introduction
2.1.1 Oncology
2.1.2 Cardiovascular Diseases
2.1.3 Neurological Diseases
2.1.4 Others
2.2 Global Genomic Biomarkers Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic Biomarkers Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic Biomarkers Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic Biomarkers Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic Biomarkers Revenue Breakdown by Type (2018-2029)
3 Genomic Biomarkers Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic and Research Laboratories
3.1.2 Hospitals
3.1.3 Others
3.2 Global Genomic Biomarkers Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic Biomarkers Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic Biomarkers Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic Biomarkers Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic Biomarkers Revenue Breakdown by Application (2018-2029)
4 Genomic Biomarkers Competition Analysis by Players
4.1 Global Genomic Biomarkers Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Biomarkers as of 2022)
4.3 Date of Key Players Enter into Genomic Biomarkers Market
4.4 Global Top Players Genomic Biomarkers Headquarters and Area Served
4.5 Key Players Genomic Biomarkers Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic Biomarkers Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Thermo Fisher Scientific
5.1.1 Thermo Fisher Scientific Profile
5.1.2 Thermo Fisher Scientific Main Business
5.1.3 Thermo Fisher Scientific Genomic Biomarkers Products, Services and Solutions
5.1.4 Thermo Fisher Scientific Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.1.5 Thermo Fisher Scientific Recent Developments
5.2 Roche
5.2.1 Roche Profile
5.2.2 Roche Main Business
5.2.3 Roche Genomic Biomarkers Products, Services and Solutions
5.2.4 Roche Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Recent Developments
5.3 Aepodia
5.3.1 Aepodia Profile
5.3.2 Aepodia Main Business
5.3.3 Aepodia Genomic Biomarkers Products, Services and Solutions
5.3.4 Aepodia Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.3.5 Myriad Genetics Recent Developments
5.4 Myriad Genetics
5.4.1 Myriad Genetics Profile
5.4.2 Myriad Genetics Main Business
5.4.3 Myriad Genetics Genomic Biomarkers Products, Services and Solutions
5.4.4 Myriad Genetics Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.4.5 Myriad Genetics Recent Developments
5.5 Eurofins Scientific
5.5.1 Eurofins Scientific Profile
5.5.2 Eurofins Scientific Main Business
5.5.3 Eurofins Scientific Genomic Biomarkers Products, Services and Solutions
5.5.4 Eurofins Scientific Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.5.5 Eurofins Scientific Recent Developments
5.6 QIAGEN
5.6.1 QIAGEN Profile
5.6.2 QIAGEN Main Business
5.6.3 QIAGEN Genomic Biomarkers Products, Services and Solutions
5.6.4 QIAGEN Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.6.5 QIAGEN Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Profile
5.7.2 Bio-Rad Laboratories Main Business
5.7.3 Bio-Rad Laboratories Genomic Biomarkers Products, Services and Solutions
5.7.4 Bio-Rad Laboratories Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories Recent Developments
5.8 Genomic Health
5.8.1 Genomic Health Profile
5.8.2 Genomic Health Main Business
5.8.3 Genomic Health Genomic Biomarkers Products, Services and Solutions
5.8.4 Genomic Health Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.8.5 Genomic Health Recent Developments
5.9 Liquid Genomics
5.9.1 Liquid Genomics Profile
5.9.2 Liquid Genomics Main Business
5.9.3 Liquid Genomics Genomic Biomarkers Products, Services and Solutions
5.9.4 Liquid Genomics Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.9.5 Liquid Genomics Recent Developments
5.10 Epigenomics
5.10.1 Epigenomics Profile
5.10.2 Epigenomics Main Business
5.10.3 Epigenomics Genomic Biomarkers Products, Services and Solutions
5.10.4 Epigenomics Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.10.5 Epigenomics Recent Developments
5.11 AROS Applied Biotechnology
5.11.1 AROS Applied Biotechnology Profile
5.11.2 AROS Applied Biotechnology Main Business
5.11.3 AROS Applied Biotechnology Genomic Biomarkers Products, Services and Solutions
5.11.4 AROS Applied Biotechnology Genomic Biomarkers Revenue (US$ Million) & (2018-2023)
5.11.5 AROS Applied Biotechnology Recent Developments
6 North America
6.1 North America Genomic Biomarkers Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomic Biomarkers Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic Biomarkers Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic Biomarkers Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic Biomarkers Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic Biomarkers Market Dynamics
11.1 Genomic Biomarkers Industry Trends
11.2 Genomic Biomarkers Market Drivers
11.3 Genomic Biomarkers Market Challenges
11.4 Genomic Biomarkers Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock